Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 127

Sort by

Sort Order Select

Journal Articles

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 5205.

https://doi.org/10.1182/blood.V126.23.5205.5205

Published: 2015

Journal Articles

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Vikas Madan, PhD, Deepika Kanojia, PhD, Li Jia, Ryoko Okamoto, PhD, Aiko Sato-Otsubo, Alexander Kohlmann, PhD, Masashi Sanada, MD PhD, Vera Grossmann, Janani Sundaresan, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Felicitas Thol, MD, Arnold Ganser, Henry Yang, PhD, Torsten Haferlach, Seishi Ogawa, MD PhD, H. Phillip Koeffler

Blood (2014) 124 (21): 4609.

https://doi.org/10.1182/blood.V124.21.4609.4609

Published: 2014

Journal Articles

Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients

Silvia Salmoiraghi, BiolSc, Greta Ubiali, BiolSc, Manuela Tosi, BiolSc, Barbara Peruta, BiolSc, Marie Lorena Guinea Montalvo, BiolSc, Elena Oldani, BiolSc, Cristina Boschini, MSc, Alexander Kohlmann, PhD, Sabina Chiaretti, Tamara Intermesoli, MD, Renato Bassan, MD, Orietta Spinelli, PhD, Alessandro Rambaldi

Blood (2014) 124 (21): 3796.

https://doi.org/10.1182/blood.V124.21.3796.3796

Published: 2014

Journal Articles

Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine

Andrea Kuendgen, MD, Catharina Müller-Thomas, MD, Petra Urbaniak, Michael Lauseker, Torsten Haferlach, MD, Tamara Alpermann, Andreia Albuquerque, PhD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Barbara Hildebrandt, PhD, Brigitte Royer-Pokora, PhD, Norbert Gattermann, MD, Rainer Haas, MD, Ulrich Germing, MD, Katharina Götze, MD

Blood (2013) 122 (21): 2757.

https://doi.org/10.1182/blood.V122.21.2757.2757

Published: 2013

Journal Articles

Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes

Andrea Kuendgen, MD, Jenny Seidler, Michael Lauseker, Torsten Haferlach, MD, Susanne Schnittger, PhD, Alexander Kohlmann, PhD, Barbara Hildebrandt, PhD, Catharina Müller-Thomas, MD, Beate Betz, PhD, Rainer Haas, MD, Norbert Gattermann, MD, Brigitte Royer-Pokora, PhD, Katharina Götze, M.D., Ulrich Germing, MD

Blood (2013) 122 (21): 2758.

https://doi.org/10.1182/blood.V122.21.2758.2758

Published: 2013

Journal Articles

Array CGH Identifies Copy Number Changes In 10% Of 520 MDS Patients With Normal Karyotype: Deletions Encompass The Genes TET2 , DNMT3A , ETV6 , NF1 , RUNX1, and STAG2 and Are Associated With Shorter Survival

Claudia Haferlach, MD, Melanie Zenger, Marita Staller, Andreas Roller, PhD, Kathrin Raitner, Jinda Holzwarth, Wolfgang Kern, MD, Susanne Schnittger, PhD, Yasunobu Nagata, MD, Seishi Ogawa, MD, PhD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 1516.

https://doi.org/10.1182/blood.V122.21.1516.1516

Published: 2013

Journal Articles

WT1 Mutations Are Secondary Events In AML and Show Varying Frequencies Within Genetic Subgroups and Different Impact On Prognosis

Susanne Schnittger, PhD, Christiane Eder, PhD, Tamara Alpermann, Frank Dicker, PhD, Madlen Ulke, Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2542.

https://doi.org/10.1182/blood.V122.21.2542.2542

Published: 2013

Journal Articles

Cytogenetic and Molecular Genetic Characterization Of MLL -PTD Positive AML In Comparison To MLL -Translocated AML

Claudia Haferlach, MD, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 2557.

https://doi.org/10.1182/blood.V122.21.2557.2557

Published: 2013

Journal Articles

TP53 Mutations Detected By Next-Generation Deep-Sequencing In Patients With Myelodysplastic Syndrome and Isolated Deletion (5q): Results From a German Multicenter Trial

Blood (2013) 122 (21): 2759.

https://doi.org/10.1182/blood.V122.21.2759.2759

Published: 2013

Journal Articles

RARS-T Patients Harbor SF3B1 Mutations In 90.2% and Can Be Characterized By Mutations In ASXL1 and Other Spliceosome Genes In Most Of The Remaining Cases

Sabine Jeromin, PhD, Christiane Eder, PhD, Sandra Weissmann, PhD, Manja Meggendorfer, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 2764.

https://doi.org/10.1182/blood.V122.21.2764.2764

Published: 2013

Journal Articles

Comparison Of Mutation Patterns Between Diagnosis and Relapse In 556 Adult Patients With AML Shows High Variability Of Stability

Susanne Schnittger, PhD, Niroshan Nadarajah, MSc, Tamara Alpermann, Christiane Eder, PhD, Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Sandra Weissmann, PhD, Annette Fasan, PhD, Simone Weber, Andreia Albuquerque, PhD, Sabine Jeromin, PhD, Manja Meggendorfer, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2013) 122 (21): 4978.

https://doi.org/10.1182/blood.V122.21.4978.4978

Published: 2013

Journal Articles

Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain

Blood (2013) 122 (21): 3986.

https://doi.org/10.1182/blood.V122.21.3986.3986

Published: 2013

Journal Articles

Algorithms and Processing Pipeline For Error Correction and Detection Of Significant Mutations In The Kinase Domain Of BCR-ABL Analyzed By Next-Generation Sequencing: Implications For Clinical Practice Of Chronic Myeloid Leukemia

Katerina Machova Polakova, Vojtech Kulvait, Jana Linhartova, Adela Brouckova, Simona Soverini, Monika Jaruskova, Caterina de Benedittis, Torsten Haferlach, MD, Michele Baccarani, MD, Giovanni Martinelli, MD, Alexander Kohlmann, PhD, Hana Klamova

Blood (2013) 122 (21): 3987.

https://doi.org/10.1182/blood.V122.21.3987.3987

Published: 2013

Journal Articles

Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis

Blood (2013) 122 (21): 2622.

https://doi.org/10.1182/blood.V122.21.2622.2622

Published: 2013

Journal Articles

Improving The Analysis Of Gene Expression Profiles By Comparing AML Blasts With Their Nearest Normal Counterparts

Nicolas Rapin, PhD, Frederik Otzen Bagger, MSc, Johan Jendholm, PhD, Helena Isabel Mora-Jensen, Msc, Anders Krogh, PhD, Alexander Kohlmann, PhD, Christian Thiede, MD, Niels Borregaard, MD, PhD, Lars Bullinger, MD, PhD, Ole Winther, PhD, Kim Theilgaard-Mönch, MD, PhD, Bo Porse, PhD

Blood (2013) 122 (21): 2568.

https://doi.org/10.1182/blood.V122.21.2568.2568

Published: 2013

Journal Articles

Diagnostic and Prognostic Utility Of a 26-Gene Panel For Deep-Sequencing Mutation Analysis In Myeloid Malignancies

Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Niroshan Nadarajah, MSc, Tamara Alpermann, Sandra Weissmann, PhD, Andreas Roller, PhD, Andreia Albuquerque, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 1547.

https://doi.org/10.1182/blood.V122.21.1547.1547

Published: 2013

Journal Articles

Molecular Screening In Blastic Plasmacytoid Dendritic Cell Neoplasms Reveals Mutations In TET2 and ASXL1 In The Majority Of Patients

Wolfgang Kern, MD, Sabrina Kuznia, MSc, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2013) 122 (21): 2581.

https://doi.org/10.1182/blood.V122.21.2581.2581

Published: 2013

Journal Articles

IGHV Mutation Status Does Not Add Prognostic Information In The Background Of Mutations In TP53 and SF3B1, and Deletions Of 17p and 11q, Which Are Independent Adverse Prognostic Parameters In CLL

Claudia Haferlach, MD, Sabine Jeromin, PhD, Sandra Weissmann, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 4110.

https://doi.org/10.1182/blood.V122.21.4110.4110

Published: 2013

Journal Articles

Risk Stratification In Chronic Lymphocytic Leukemia Patients With IGHV3-21 Gene Usage According To Presence Of Stereotypy and Mutations In SF3B1

Sabine Jeromin, PhD, Frank Dicker, PhD, Katharina Bayer, Sandra Weissmann, PhD, Christiane Eder, PhD, Manja Meggendorfer, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 4114.

https://doi.org/10.1182/blood.V122.21.4114.4114

Published: 2013

Journal Articles

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Alexander Kohlmann, PhD, Andreas Roller, PhD, Jennifer Kienast, Sabine Denzel, PhD, Vera Grossmann, PhD, Niroshan Nadarajah, MSc, Tamara Alpermann, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2998.

https://doi.org/10.1182/blood.V122.21.2998.2998

Published: 2013

NARROW

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients

Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine

Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes

Array CGH Identifies Copy Number Changes In 10% Of 520 MDS Patients With Normal Karyotype: Deletions Encompass The Genes TET2 , DNMT3A , ETV6 , NF1 , RUNX1, and STAG2 and Are Associated With Shorter Survival

WT1 Mutations Are Secondary Events In AML and Show Varying Frequencies Within Genetic Subgroups and Different Impact On Prognosis

Cytogenetic and Molecular Genetic Characterization Of MLL -PTD Positive AML In Comparison To MLL -Translocated AML

TP53 Mutations Detected By Next-Generation Deep-Sequencing In Patients With Myelodysplastic Syndrome and Isolated Deletion (5q): Results From a German Multicenter Trial

RARS-T Patients Harbor SF3B1 Mutations In 90.2% and Can Be Characterized By Mutations In ASXL1 and Other Spliceosome Genes In Most Of The Remaining Cases

Comparison Of Mutation Patterns Between Diagnosis and Relapse In 556 Adult Patients With AML Shows High Variability Of Stability

Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain

Algorithms and Processing Pipeline For Error Correction and Detection Of Significant Mutations In The Kinase Domain Of BCR-ABL Analyzed By Next-Generation Sequencing: Implications For Clinical Practice Of Chronic Myeloid Leukemia

Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis

Improving The Analysis Of Gene Expression Profiles By Comparing AML Blasts With Their Nearest Normal Counterparts

Diagnostic and Prognostic Utility Of a 26-Gene Panel For Deep-Sequencing Mutation Analysis In Myeloid Malignancies

Molecular Screening In Blastic Plasmacytoid Dendritic Cell Neoplasms Reveals Mutations In TET2 and ASXL1 In The Majority Of Patients

IGHV Mutation Status Does Not Add Prognostic Information In The Background Of Mutations In TP53 and SF3B1, and Deletions Of 17p and 11q, Which Are Independent Adverse Prognostic Parameters In CLL

Risk Stratification In Chronic Lymphocytic Leukemia Patients With IGHV3-21 Gene Usage According To Presence Of Stereotypy and Mutations In SF3B1

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only